Correlation Between ACRO Biomedical and Processa Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both ACRO Biomedical and Processa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ACRO Biomedical and Processa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ACRO Biomedical Co and Processa Pharmaceuticals, you can compare the effects of market volatilities on ACRO Biomedical and Processa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ACRO Biomedical with a short position of Processa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of ACRO Biomedical and Processa Pharmaceuticals.

Diversification Opportunities for ACRO Biomedical and Processa Pharmaceuticals

0.56

Correlation Coefficient

ACRO Biomedical  Processa Pharmaceuticals

Very weak diversification

The 3 months correlation between ACRO and Processa is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding ACRO Biomedical Co and Processa Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Processa Pharmaceuticals and ACRO Biomedical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ACRO Biomedical Co are associated (or correlated) with Processa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Processa Pharmaceuticals has no effect on the direction of ACRO Biomedical i.e., ACRO Biomedical and Processa Pharmaceuticals go up and down completely randomly.

Pair Corralation between ACRO Biomedical and Processa Pharmaceuticals

Given the investment horizon of 90 days ACRO Biomedical Co is expected to under-perform the Processa Pharmaceuticals. But the pink sheet apears to be less risky and, when comparing its historical volatility, ACRO Biomedical Co is 2.31 times less risky than Processa Pharmaceuticals. The pink sheet trades about -0.13 of its potential returns per unit of risk. The Processa Pharmaceuticals is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  25.00  in Processa Pharmaceuticals on May 15, 2025 and sell it today you would lose (2.00) from holding Processa Pharmaceuticals or give up 8.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	98.39%
Values	Daily Returns

ACRO Biomedical Co  vs.  Processa Pharmaceuticals

ACRO Biomedical

Risk-Adjusted Performance

Weakest

Over the last 90 days ACRO Biomedical Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's fundamental drivers remain very healthy which may send shares a bit higher in September 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Processa Pharmaceuticals

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Processa Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating basic indicators, Processa Pharmaceuticals sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with ACRO Biomedical and Processa Pharmaceuticals

The main advantage of trading using opposite ACRO Biomedical and Processa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ACRO Biomedical position performs unexpectedly, Processa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Processa Pharmaceuticals will offset losses from the drop in Processa Pharmaceuticals' long position.

The idea behind ACRO Biomedical Co and Processa Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.